Gandou Bushen Decoction Ameliorates Cognitive Impairment in Wilson Disease Model TX Mice by Regulating Melatonin Synthesis via the SIRT3/FOXO3α Pathway
Abstract
Melatonin has been shown to have neuroprotective effects. This study is aimed at observing the effects of copper deposition on cognitive function in a toxic milk (TX) mouse model of Wilson disease (WD), and investigating the effects and mechanisms of action of Gandou Bushen Decoction (GDBSD) on melatonin synthesis and pineal function in the WD model mice.
Methods A total of 30 homozygous TX mice were randomly assigned to 3 groups (n = 10 in each group), including a WD group, a GDBSD group, and a dimercaptosuccinic acid (DMSA) group. A total of 10 DL mice were included in the normal control (NC) group. The structure and copper content of pineal gland tissues, oxidative stress and apoptosis-related markers, and serum melatonin levels were evaluated using hematoxylin-eosin (HE) staining, enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western blot.
Results Compared with the NC group, the WD group exhibited decreased learning and cognitive abilities (P < 0.05), damaged pineal gland structure, increased copper content, reactive oxygen species (ROS) levels, and mitochondrial damage rate in the pineal gland (P < 0.01), altered levels of melatonin and oxidative stress-related markers (P < 0.05), upregulated expression levels of pro-apoptotic proteins Bax and Caspase-3, and decreased expression of the anti-apoptotic protein Bcl-2 (P < 0.01). After treatment with GDBSD and DMSA, the SIRT3/FOXO3α signaling pathway was activated, the copper content in the pineal gland was reduced, and oxidative stress and apoptosis-related damages were improved, leading to an improvement in learning and memory abilities (P < 0.05).
Conclusion GDBSD can alleviate cognitive impairments in WD mice caused by pineal gland copper deposition by inhibiting oxidative stress and apoptosis in the pineal gland. The underlying molecular mechanism is associated with the regulation of the SIRT3/FOXO3α signaling pathway.
Keywords: Wilson disease, Cognitive impairment, Gandou Bushen Decoction, Melatonin, Pineal gland
Full Text:
PDFReferences
KASZTELAN-SZCZERBINSKA B, CICHOZ-LACH H. Wilson's disease: an update on the diagnostic workup and management. J Clin Med, 2021, 10(21): 5097. doi: 10.3390/jcm10215097.
ZHANG Y, ZHOU Q, LU L, et al. Copper induces cognitive impairment in mice via modulation of cuproptosis and CREB signaling. Nutrients, 2023, 15(4): 972. doi: 10.3390/nu15040972.
GROMADZKA G, ANTOS A, SORYSZ Z, et al. Psychiatric symptoms in Wilson's disease-consequence of ATP7B gene mutations or just coincidence?-Possible causal cascades and molecular pathways. Int J Mol Sci, 2024, 25(22): 12354. doi: 10.3390/ijms252212354.
WANG X, SHAO N, ZHANG X, et al. Ferulic acid activates SIRT1-mediated ferroptosis signaling pathway to improve cognition dysfunction in Wilson's disease. Neuropsychiatr Dis Treat, 2023, 19: 2681-2696. doi: 10.2147/NDT.S443278.
WANG X, CHEN H, ZHANG X, et al. Therapeutic targets and natural product screening for cognitive impairments associated with ferroptosis in Wilson's disease. Am J Chin Med, 2024, 52(8): 2423-2452. doi: 10.1142/S0192415X24500927.
DONG J, XIANG G, XIA X, et al. Aberrant copper metabolism and hepatic inflammation cause neurological manifestations in a mouse model of Wilson's disease. J Neuroinflammation, 2024, 21(1): 235. doi: 10. 1186/s12974-024-03178-5.
DONG J, WANG X, XU C, et al. Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson's disease. Cell Death Dis, 2021, 12(1): 87. doi: 10.1038/s41419-021-03397-1.
FERRO M, MORANTE I, NISHINO F A, et al. Melatonin influence on miRNA expression in sperm, hypothalamus, pre-frontal cortex and cerebellum of Wistar rats. PLoS One, 2025, 20(1): e0312403. doi: 10.1371/journal.pone.0312403.
TCHEKALAROVA J, KRUSHOVLIEVA D, IVANOVA P, et al. The role of melatonin deficiency induced by pinealectomy on motor activity and anxiety responses in young adult, middle-aged and old rats. Behav Brain Funct, 2024, 20(1): 3. doi: 10.1186/s12993-024-00229-y.
KORF H W, Von GALL C. Mouse models in circadian rhythm and melatonin research. J Pineal Res, 2024, 76(5): e12986. doi: 10.1111/jpi. 12986.
SONG J. Pineal gland dysfunction in Alzheimer's disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis. Mol Neurodegener, 2019, 14(1): 28. doi: 10.1186/s13024-019-0330-8.
ÇIÇEK F, UÇAR İ, SEBER T, et al. Investigation of the relationship of sleep disorder occurring in fibromyalgia with central nervous system and pineal gland volume. Acta Neuropsychiatr, 2024: 1-8. doi: 10.1017/neu. 2024.49.
VUKOVIĆ M, NOSEK I, BOBAN J, et al. Pineal gland volume loss in females with multiple sclerosis. Front Neuroanat, 2024, 18: 1386295. doi: 10.3389/fnana.2024.1386295.
WANG Z, ZHOU F, DOU Y, et al. Melatonin alleviates intracerebral hemorrhage-induced secondary brain injury in rats via suppressing apoptosis, inflammation, oxidative stress, DNA damage, and mitochondria injury. Transl Stroke Res, 2018, 9(1): 74-91. doi: 10.1007/s12975-017-0559-x.
TASSONE G, KOLA A, VALENSIN D, et al. Dynamic interplay between copper toxicity and mitochondrial dysfunction in Alzheimer's disease. Life (Basel), 2021, 11(5): 386. doi: 10.3390/life11050386.
PARMAR P, DAYA S. The effect of copper on (3H)-tryptophan metabolism in organ cultures of rat pineal glands. Metab Brain Dis, 2001, 16(3/4): 199-205. doi: 10.1023/a:1012545112031.
WEN Y, ZHAO C, CHEN J, et al. Gandouling regulates ferroptosis and improves neuroinflammation in Wilson's disease through the LCN2/NLRP3 signaling pathway. J Inflamm Res, 2024, 17: 5599-5618. doi: 10.2147/JIR.S465341.
LIANG F, DONG T, TIAN L W, et al. Randomized controlled trial and correlation analysis of Gandouling tablet in treatment of abnormal lipid metabolism of Wilson's disease with turbid phlegm and blood stasis. Chin J Exp Tradit Med Form, 2024, 30(12): 121-128. doi: 10.13422/j.cnki.syfjx. 20241592.
ZHANG J, TANG L L, LI L Y, et al. Gandouling tablets inhibit excessive mitophagy in toxic milk (TX) model mouse of Wilson disease via pink1/parkin pathway. Evid Based Complement Alternat Med, 2020, 2020: 3183714, doi: 10.1155/2020/3183714.
LIU Y H, WU F, YU X F, et al. Effects of Eucommia ulmoides extract on learning and cognitive functions in APP/PS1 mice via the HPG axis. J Chin Med Mater, 2022, 45(8): 1964-1968. doi: 10.13863/j.issn1001-4454. 2022.08.033.
HUANG Y, ZHANG X, CHEN L, et al. Lycium barbarum ameliorates neural damage induced by experimental ischemic stroke and radiation exposure. Front Biosci (Landmark Ed), 202, 28(2): 38. doi: 10.31083/j.fbl2802038.
WANG S, MA J, ZENG Y, et al. Icariin, an up-and-coming bioactive compound against neurological diseases: network pharmacology-based study and literature review. Drug Des Devel Ther, 2021, 15: 3619-3641. doi: 10.2147/DDDT.S310686.
LEE H S, KIM J M, LEE H L, et al. Eucommia ulmoides leaves alleviate cognitive dysfunction in dextran sulfate sodium (DSS)-induced colitis mice through regulating JNK/TLR4 signaling pathway. Int J Mol Sci,
Refbacks
- There are currently no refbacks.
